Nature Communications

EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge

2026-01-14

Full text

DOI https://doi.org/10.1038/s41467-026-68424-1